Skip to main content
Molecular Imaging and Radionuclide Therapy logoLink to Molecular Imaging and Radionuclide Therapy
. 2019 Sep 6;28(3):126–128. doi: 10.4274/mirt.galenos.2018.59251

PET/CT Findings of a Patient with Cardiac Metastasis of Subungual Malign Melanoma

Subungual Malign Melanom Tanılı Hastanın PET/BT Görüntülemesinde Saptanan Kardiyak Metastaz

Özgül Ekmekçioğlu 1,*, Pelin Arıcan 1, Şermin Meşe 2, Nihal Kaplan 2, Mesut Kafi 1, Duygu Şimşek 1, Mehmet Şükrü Ertürk 3
PMCID: PMC6746008  PMID: 31507147

Abstract

A 58-year old patient with a history of subungual malign melanoma was referred to our department for a 18F-FDG positron emission tomography (PET)/computed tomography (CT) whole body scan. An unexpected 18F-FDG uptake in left ventricule which mimicked either trombus or physiological papillary muscle was detected. Filling defect of intravenous contrast in CT images was also demonstrated in left ventricule cavity. Magnetic resonance imaging scan confirmed cardiac mass with metastatic features of malign melanoma in left ventricule.

Keywords: Malign melanoma, PET/CT, subungual, 18F-FDG

Figure 1.

Figure 1

A 58-year old patient with a history of malign melanoma was referred to our PET/CT department for re-staging. Patient was initially diagnosed with excisional biopsy from the nail bed of his first left toe 4 years ago. Inguinal lymph node biopsy revealed negative for metastases at the time of diagnosis. Metastatic lymph nodes were detected in left inguinal region which was confirmed with biopsy 3 years later. Patient was under immunotherapy and had no symptoms either in the control or in the day of scan.

PET/CT scan demonstrated increased cardiac (18F-FDG) 18-fluoro-deoxy-glucose uptake in left ventricule (A). CT images revealed filling defect of the intravenous contrast in left ventricular cavity which was suggestive of a lesion or a benign pathology like papillary muscle hypertrophy (B). MRI scan showed T1 hyperintensity with gadolinium enhancement in late phase of contrast giving process, 4x3 cm sized T2 hypointensity compatible with melanoma metastasis starting from papillary muscle in apical region, infiltrating through myocardium and extending to pericardium (C, D). Biopsy could not be performed from cardiac mass due to high mortality risk of the patient.

Cardiac masses are mostly originated from metastatic spread. Lung cancer, breast cancer and non-hodgkin lymphoma are the most common origins for cardiac metastases (1,2). Malign melanoma has also high potential to metastasize especially to lungs, liver and bones. However, cardiac metastases from melanoma are oftenly detected in autopsy series rather than detected with clinical presentation (3).18F-FDG uptake could vary in cardiac tissue and it is usually shown to be helpful in differentiating benign lesions from malignancy (4). In addition to this high uptake in myocardium and the left ventricule can be observed physiologically in 18F-FDG PET images (5). Papillary muscle hypertrophy or trombus in ventriculary cavity could show increased 18F-FDG uptake in PET images (6,7). As seen in our case, cardiac uptake should be checked carefully to differentiate physiological uptake which could be normally seen in cardiac tissue. Diversely, intravenous contrast is not routinely used in every PET/CT scan protocol. It has been proven to be helpful in identifying pathologic changes in organs with normal findings in unenhanced CT (8). Our images also demonstrated the usage of intravenous contrast with the filling defect seen in left ventricular cavity.

Footnotes

Ethics

Informed Consent: An explanatory informed consent form is signed and dated both by the doctor and by patient.

Peer-review: Eternally peer-reviewed.

Authorship Contributions

Surgical and Medical Practices: Ş.M., Concept: Ö.E., P.A., Design: N.K., P.A., Data Collection or Processing: M.K., D.Ş., Analysis or Interpretation: M.Ş.E., Literature Search: D.Ş., Writing: Ö.E.

Conflict of Interest: No conflict of interest was declared by the authors.

Financial Disclosure: The authors declared that this study received no financial support.

References

  • 1.Lichtenberger JP, Reynolds DA, Keung J, Keung E, Carter BW. Metastasis to the Heart: A Radiologic Approach to Diagnosis With Pathologic Correlation. AJR Am J Roentgenol. 2016;207:764–772. doi: 10.2214/AJR.16.16148. [DOI] [PubMed] [Google Scholar]
  • 2.Goldberg AD, Blankstein R, Padera RF. Tumors metastatic to the heart. Circulation. 2013;128:1790–1794. doi: 10.1161/CIRCULATIONAHA.112.000790. [DOI] [PubMed] [Google Scholar]
  • 3.Poggi R, Pantaleo MA, Benedetti G, Biasco G. Cardiac metastasis of melanoma. Melanoma Res. 2005;15:315–316. doi: 10.1097/00008390-200508000-00013. [DOI] [PubMed] [Google Scholar]
  • 4.Maurer AH, Burshteyn M, Adler LP, Steiner RM. How to Differentiate Benign versus Malignant Cardiac and Paracardiac 18F FDG Uptake at Oncologic PET/CT. Radiographics. 2011;31:1287–1305. doi: 10.1148/rg.315115003. [DOI] [PubMed] [Google Scholar]
  • 5.Fukuchi K, Ohta H, Matsumura K, Ishida Y. Benign variations and incidental abnormalities of myocardial FDG uptake in the fasting state as encountered during routine oncology positron emission tomography studies. Br J Radiol. 2007;80:3–11. doi: 10.1259/bjr/92105597. [DOI] [PubMed] [Google Scholar]
  • 6.Lin EC. Isolated papillary muscle uptake on FDG PET/CT. Clin Nucl Med. 2007;32:76–78. doi: 10.1097/01.rlu.0000249516.53979.ed. [DOI] [PubMed] [Google Scholar]
  • 7.Chaudhuri KG, Revels JW, Yadwadkar KS, Johnson LS. Intense 18F-FDG Uptake in an Organizing Right Atrial Thrombus Mimicking Malignancy. Radiology Case Rep. 2017;12:449–454. doi: 10.1016/j.radcr.2017.04.023. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Cronin CG, Prakash P, Blake MA. Oral and IV contrast agents for the CT portion of PET/CT. AJR Am J Roentgenol. 2010;195:5–13. doi: 10.2214/AJR.09.3844. [DOI] [PubMed] [Google Scholar]

Articles from Molecular Imaging and Radionuclide Therapy are provided here courtesy of Galenos Yayinevi

RESOURCES